Recent Finacing
Recent Raise
EsoCap AG develops a topical esophageal drug‑delivery platform and is advancing ESO‑101 in a Phase II ACESO trial for eosinophilic esophagitis while exploring Barrett’s and reflux applications.
Focus Areas
Funding round
See the team members at EsoCap.
